ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 268 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $704,095 | +606.6% | 27,091 | +677.6% | 0.01% | +500.0% |
Q1 2024 | $99,642 | -76.4% | 3,484 | -74.7% | 0.00% | -60.0% |
Q4 2023 | $422,066 | +136.5% | 13,793 | +107.7% | 0.01% | -16.7% |
Q3 2023 | $178,470 | -43.3% | 6,642 | -24.7% | 0.01% | -40.0% |
Q2 2023 | $314,735 | +190648.5% | 8,826 | +35.7% | 0.01% | +100.0% |
Q1 2023 | $165 | -16.2% | 6,506 | +33.6% | 0.01% | -37.5% |
Q4 2022 | $197 | -100.0% | 4,868 | -68.2% | 0.01% | 0.0% |
Q3 2022 | $505,000 | +77.2% | 15,294 | +88.6% | 0.01% | +33.3% |
Q2 2022 | $285,000 | +119.2% | 8,109 | +185.8% | 0.01% | +500.0% |
Q1 2022 | $130,000 | -76.7% | 2,837 | -66.4% | 0.00% | -90.0% |
Q4 2021 | $559,000 | -34.5% | 8,433 | -38.3% | 0.01% | -54.5% |
Q3 2021 | $854,000 | +20.5% | 13,674 | +59.6% | 0.02% | +22.2% |
Q2 2021 | $709,000 | -30.5% | 8,568 | -44.3% | 0.02% | +5.9% |
Q1 2021 | $1,020,000 | +93.5% | 15,374 | +123.8% | 0.02% | +6.2% |
Q4 2020 | $527,000 | +146.3% | 6,869 | +37.8% | 0.02% | +700.0% |
Q3 2020 | $214,000 | -80.5% | 4,983 | -80.4% | 0.00% | -95.6% |
Q2 2020 | $1,099,000 | +272.5% | 25,457 | +446.9% | 0.04% | +80.0% |
Q4 2019 | $295,000 | +23.9% | 4,655 | -44.9% | 0.02% | +56.2% |
Q3 2019 | $238,000 | +2063.6% | 8,453 | +2008.0% | 0.02% | +1500.0% |
Q2 2019 | $11,000 | +450.0% | 401 | +301.0% | 0.00% | – |
Q1 2019 | $2,000 | -90.0% | 100 | -93.6% | 0.00% | -100.0% |
Q4 2018 | $20,000 | 0.0% | 1,573 | +51.2% | 0.00% | 0.0% |
Q3 2018 | $20,000 | -78.0% | 1,040 | -95.8% | 0.00% | -91.7% |
Q4 2017 | $91,000 | – | 24,715 | – | 0.01% | – |
Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2017 | $89,000 | +790.0% | 54,803 | +755.4% | 0.01% | +900.0% |
Q4 2016 | $10,000 | – | 6,407 | +106683.3% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 6 | -99.5% | 0.00% | -100.0% |
Q2 2016 | $7,000 | – | 1,274 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |